Updated: January 21, 2026
How to Save Money on Amifampridine (Firdapse) in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

- What Does Amifampridine (Firdapse) Actually Cost?
- Option 1: Catalyst Pathways Patient Assistance Program
- Option 2: Commercial Insurance Coverage
- Option 3: Medicare Part D — The $2,000 Annual Cap
- Option 4: NORD RareCare Program
- What About GoodRx and Pharmacy Coupons?
- Tips for Maximizing Your Savings on Firdapse
Overview
Amifampridine (Firdapse) has a list price exceeding $375,000 per year. But most insured patients pay far less. Here are all the savings options available in 2026.
Is Amifampridine in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Amifampridine near you.
Amifampridine (Firdapse) carries one of the most alarming price tags in specialty medicine — historically around $375,000 per year. Seeing that number is enough to make any patient feel hopeless about affording this medication. But the reality for most patients is far better than that list price suggests. Thanks to manufacturer support programs, insurance coverage, and patient assistance options, the majority of LEMS patients can access Firdapse at a manageable cost. Here's everything you need to know about reducing the cost of amifampridine in 2026.
What Does Amifampridine (Firdapse) Actually Cost?
At list price, Firdapse costs approximately $31,000–$34,000 for 120 tablets (roughly a 30–40 day supply depending on dosing). For the majority of patients, however, the out-of-pocket cost is dramatically lower thanks to insurance coverage and patient assistance programs.
Check live stock now.
Option 1: Catalyst Pathways Patient Assistance Program
The most powerful savings tool for most Firdapse patients is the Catalyst Pathways program, offered by Catalyst Pharmaceuticals. This is the first call you should make when your doctor prescribes amifampridine.
Commercially insured patients: Eligible patients may pay $0 per monthly prescription. Patients enrolled in the program average less than $2 per month out of pocket.
Coverage gap assistance: Free medication is available for eligible patients experiencing a gap in coverage between insurance investigation and confirmation.
Uninsured and underinsured patients: Case managers can help determine eligibility for additional assistance programs.
How to enroll: Call 1-833-422-8259 or visit firdapse.com/support-and-savings/. You will need your doctor to help fill out and submit the enrollment form.
Option 2: Commercial Insurance Coverage
Most major commercial insurance plans (UnitedHealthcare, Cigna, Aetna, BCBS, Humana) will cover amifampridine with prior authorization for confirmed LEMS patients. Firdapse is typically placed on Tier 4 or Tier 5 (specialty tier), which usually means coinsurance (paying a percentage of the drug's cost) rather than a fixed copay. Without the manufacturer's assistance program, this coinsurance can still be substantial — but with Catalyst Pathways, it's typically reduced to zero.
Option 3: Medicare Part D — The $2,000 Annual Cap
For Medicare Part D beneficiaries, the 2025 redesign of the program introduced a critical change: a $2,000 annual out-of-pocket cap. Once you've spent $2,000 on covered Part D drugs in a calendar year, you pay $0 for the rest of the year — regardless of how expensive the drugs are. For Firdapse patients on Medicare, this cap is a significant financial protection.
Note: Federal law prohibits the use of manufacturer copay cards for Medicare beneficiaries. If you are on Medicare, you cannot use the Catalyst Pathways commercial copay assistance. However, need-based patient assistance programs may still be available — ask a Catalyst case manager.
Option 4: NORD RareCare Program
The National Organization for Rare Diseases (NORD) operates the RareCare program, which provides financial assistance to patients with rare diseases. NORD has distributed over $174 million in assistance. The program can help with:
Medication cost assistance
Insurance premium assistance
Diagnostic testing support
Contact NORD RareCare: 800-999-6673 or rarediseases.org
What About GoodRx and Pharmacy Coupons?
GoodRx and similar drug coupon services are designed for retail pharmacy medications. Amifampridine (Firdapse) is dispensed exclusively through specialty pharmacies where GoodRx coupons are not accepted. GoodRx shows a starting price of approximately $34,000 for Firdapse — this is the cash price at a specialty pharmacy without any assistance, and it is not a discounted price. For amifampridine, the Catalyst Pathways program is far more effective than any coupon service.
Found
Rate
on average
Tips for Maximizing Your Savings on Firdapse
Enroll in Catalyst Pathways before your first fill — call 1-833-422-8259 at the same time your doctor prescribes the medication.
If you are on Medicare, apply for manufacturer assistance early in the year, before reaching the Part D coverage gap.
Ask about NORD RareCare if you have additional financial hardship — it can help with insurance premiums and other out-of-pocket costs.
If your insurer denies coverage, appeal the decision. Amifampridine is the only FDA-approved oral therapy for LEMS, and appeals based on medical necessity are often successful.
If you need help finding a pharmacy that can fill your prescription, medfinder calls pharmacies on your behalf to find which ones have your medication available.
Visit medfinder.com to get started, or read our guide on how to find amifampridine in stock near you.
Frequently Asked Questions
With insurance and the Catalyst Pathways copay assistance program, most commercially insured patients pay $0 per month for Firdapse. Patients enrolled in the program average less than $2 per month out of pocket. Without assistance, commercial insurance coinsurance on Tier 5 specialty drugs can be 25–50% of cost. Medicare Part D patients benefit from the 2025 $2,000 annual out-of-pocket cap.
Yes. Catalyst Pharmaceuticals offers the Catalyst Pathways program (1-833-422-8259 or firdapse.com/support-and-savings/). It provides $0 monthly copay for eligible commercially insured patients, free bridge medication during coverage gaps, specialty pharmacy coordination, and referrals to additional assistance programs like NORD RareCare.
Federal law prohibits the use of manufacturer copay cards for Medicare beneficiaries, so Medicare patients cannot use the commercial copay card. However, need-based patient assistance programs may be available for Medicare patients — contact Catalyst Pathways at 1-833-422-8259 to explore options. The 2025 Medicare Part D $2,000 annual out-of-pocket cap provides significant protection for specialty drug costs.
No — GoodRx coupons are not accepted at specialty pharmacies, and Firdapse is only available through specialty pharmacies. The GoodRx listed price of ~$34,000 reflects the cash price without any assistance, not a discount. Use the Catalyst Pathways program instead, which is far more effective for Firdapse cost savings.
You have the right to appeal. Most denials occur due to incomplete initial documentation. Your neurologist can request a peer-to-peer review with the insurer's medical director, which is often effective in overturning denials. You can also request a formulary exception if Firdapse is non-formulary. NORD RareCare (800-999-6673) and Catalyst Pathways can provide additional support during the appeals process.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Amifampridine also looked for:
More about Amifampridine
39,483 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





